Clinical trial

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

NCT01141023

Study summary

ClinicalTrials.gov

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention DaTscan Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE2

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

DaTscanDRUG

Sponsors & collaborators

Ken Marek, MDlead sponsor

Institute for Neurodegenerative Disorderscollaborator

Mapped research locations

New YorkNew York, United States2 HoustonTexas, United States1 BostonMassachusetts, United States1 ChicagoIllinois, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 AtlantaGeorgia, United States1 San FranciscoCalifornia, United States1 BarcelonaSpain1 LondonUnited Kingdom1 SeattleWashington, United States1 ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01141023 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.